Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension

Journal of Hypertension

Volumn 16, Issue 12, 1998, Pages 1823-1829

  Liu, Lisheng ^a   Wang, Ji Guang ^a,b   Gong, Lansheng ^c   Liu, Guozhang ^a   Staessen, Jan A ^b,d  

^a FUWAI HOSPITAL   (China)

^b KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Calcium channel blocker; Dihydropyridine; Isolated systolic hypertension; Mortality; Prevention; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; CHOLESTEROL; HYDROCHLOROTHIAZIDE; NITRENDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SITTING; STROKE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 0031769003     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816120-00016     Document Type: Article

References (11)

1. Wu K, Xie L, Chen D, Chen J. The natural history of borderline hypertension in a Chinese population. J Hum Hypertens 1997; 11:95-100.
2. He J, Klag MJ, Wu Z, Whelton PK. Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke. Stroke 1995; 26:2228-2232.
3. He J, Klag MJ, Wu Z, Whelton PK. Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors. Stroke 1995; 26:2222-2227.
4. Li SC, Schoenberg BS, Wang CC, Cheng XM, Bolis CL, Wang KJ. Cerebrovascular disease in the People's Republic of China: epidemiologic and clinical features. Neurology 1985; 35:1708-1713.
5. Collaborative Group Coordinating Center. Systolic hypertension in the elderly: Chinese trial (Syst-China): interim report. Chin J Cardiol 1992; 20:270-275.
6. Wang JG, Liu G, Wang X, Zhang S, Sun M, Pan X, et al. Long-term blood pressure control in older Chinese patients with isolated systolic hypertension: a progress report on the Syst-China trial. J Hum Hypertens 1996; 10:735-742.
7. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255-3264.
8. Amery A, Birkenhäger W, Bulpitt CJ, Clement D, de Leeuw P, Dollery CT, et al. Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging Clin Exp Res 1991; 3:287-302.
9. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350:757-764 [correction 350:1636].
10. World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death, based on the recommendations of the Ninth Revision Conference, 1975, and adopted by the Twenty-Ninth World Health Assembly, vol 1. Geneva: WHO; 1977.
11. The Systolic Hypertension in the Elderly Program Cooperative Research Group. Implications of the Systolic Hypertension in the Elderly Program. Hypertension 1993; 21:335-343.